Once-yearly zoledronic acid in hip fracture prevention
Oddom Demontiero, Gustavo DuqueAging Bone Research Program, Nepean Clinical School, University of Sydney, Penrith, NSW, Australia; Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW, AustraliaAbstract: Osteoporosis is an escalating global problem. Hip fractures, the most catastrophic co...
Guardado en:
Autores principales: | Oddom Demontiero, Gustavo Duque |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9df2c8fdb1b4560859e08926227e858 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011) -
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
por: Shi C, et al.
Publicado: (2018) -
Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009) -
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009) -
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
por: Alex Fisher, et al.
Publicado: (2010)